Understanding the enhanced mRNA functional delivery of lipid nanoparticles formulated using a high-throughput platform
Biopharmaceutical company, AstraZeneca, recently developed an automated technique to generate lipid nanoparticles for mRNA delivery and used neutron scattering to investigate how it compared to standard production methods.